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ABSTRACT 
Background: Pediatric functional abdominal pain disorders (FAPDs) are prevalent and 
associated with painful symptoms, low quality of life, and functional impairments. The origin 
is likely multifactorial and includes psychological factors (e.g., anxiety and coping 
mechanisms), biological factors (e.g., visceral sensitivity and gut microbiota), and social 
factors (e.g., interaction with parents or teachers). There is limited support for dietary and 
pharmacological treatments in FAPDs, but support for the effectiveness of cognitive 
behavioral therapy (CBT) is growing. 
Aims: The overall aim of the thesis was to develop and evaluate a therapist-supported 
exposure-based CBT for children 8-12 years with FAPDs, which could, if proven effective, 
increase accessibility of treatments for children with FAPDs. The specific aims were to: 
- Assess feasibility, acceptability, and potential effectiveness of the preliminary protocol of 
exposure-based CBT in a face-to-face setting (Study I). 
- Assess feasibility, acceptability, and potential effectiveness of the exposure-based CBT 
converted to an internet platform (Internet-CBT, Study II).  
- Evaluate effectiveness and cost effectiveness of the Internet-CBT compared with treatment 
as usual (Study III).  
- Investigate if gastrointestinal-specific anxiety and avoidance behaviors mediated a change 
in gastrointestinal symptoms in Internet-CBT compared with treatment as usual and if 
baseline values of the proposed mediators moderated the mediation (Study IV). 
Methods: All participants were children 8-12 years with FAPDs referred to the studies by 
their physicians. Treatment consisted of therapist-supported exposure-based CBT, delivered 
face-to-face (Study I) or online (studies II-IV) along with parental sessions or modules. All 
measures were self-assessed by children and parents. Primary outcome was pain intensity 
(Study I) and gastrointestinal symptoms (Study II-IV). Secondary outcomes included quality 
of life, school absence, anxiety, and parental responses to their children´s symptoms (Studies 
I-III), cost effectiveness and parental catastrophizing (Study III), gastrointestinal-specific 
anxiety (Study II-IV), and avoidance behavior (Study I-IV). Statistical analyses used to test 
within- and between-group effects were t-tests (Study I) and multi-level linear mixed models 
(Study II and III). Differences in costs between groups were assessed with generalized linear 
models (Study III). Univariate and multivariate growth models were used to assess mediation 
and moderated mediation (Study IV). 
Results: Therapist-supported exposure-based CBT, delivered face-to-face or online, rendered 
high adherence and treatment completion (Study I-III). Participating children and parents 
were satisfied with the treatment and perceived it to be helpful in dealing with abdominal 
symptoms (Study I-III). There were significant treatment effects in gastrointestinal 
symptoms, quality of life, gastrointestinal-specific anxiety, avoidance behavior, anxiety, 
parental catastrophizing, and parental responses to their child’s symptoms for Internet-CBT 
when compared with treatment as usual (Study III). Internet-CBT was found to be cost 
effective and even cost saving compared with treatment as usual (Study III). A reduction in 
gastrointestinal-specific anxiety and avoidance behavior mediated a reduction in 
gastrointestinal symptoms for children receiving Internet-CBT compared with children 
receiving treatment as usual (Study IV). Baseline values of gastrointestinal specific-anxiety 
and avoidance behavior moderated the mediation (Study IV). 
Conclusions: Internet-CBT based on exposure exercises and parental support for children 
with FAPDs is feasible, acceptable, clinically effective, and cost effective compared with 
treatment as usual. Gastrointestinal-specific anxiety and avoidance behavior are potential 
mechanisms of change in exposure-based Internet-CBT compared with treatment as usual. 
Internet-CBT seems to be particularly effective for children with high levels of 
gastrointestinal-specific anxiety and avoidance behaviors. The treatment has the potential to 
increase the availability of evidence-based treatments a large group of children with FAPDs. 
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1 INTRODUCTION 
Imagine abdominal pain so intense you can barely stand up straight. You collapse on the 
couch and roll up like bowl. Your stomach is swollen like a balloon and you feel nauseous. 
Then imagine this happening again and again. Your doctor assures you all tests are OK. But 
what if she is mistaken?  
This is the reality for many children. Functional abdominal pain disorders are so prevalent 
that in every classroom 2-4 children are likely affected. For many children the symptoms lead 
to impairments in their everyday lives.  
Studies in adults suggest that the behavioral response to one’s own abdominal symptoms 
affect how subsequent symptoms are perceived. A strong and forceful reaction confirms the 
importance of the abdominal symptoms and likely leads to prioritization and amplification of 
them. In children parental behavior is also a factor.  Parents’ responses to the child’s pain 
expressions have been shown to influence how symptoms are perceived and managed by the 
child. In other words, the behaviors of both children and their parents are of great importance 
in the treatment of pediatric functional abdominal pain disorders. 
The treatment developed and evaluated in this thesis was designed to empower children to 
take back the control of their symptoms and lives. With support from their therapists the 
children strived hard and to a high extent succeeded in their efforts. The children showed that 
they and not their stomachs are in charge and that they had attained guts over fear. 
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2 BACKGROUND 
2.1 FUNCTIONAL ABDOMINAL PAIN DISORDERS (FAPDS) 
Long-lasting abdominal pain was first described by British pediatrician John Apley in 1958 
as recurrent abdominal pain.1 In the 1980’s researchers united in forming more specific 
criteria for functional abdominal disorders, the Rome criteria. The Rome III criteria were 
released in 20062 and the Rome IV criteria were released in 2016.3 Pediatric functional 
abdominal pain disorders (FAPDs) according to the Rome IV criteria are characterized by 
abdominal pain or discomfort that after appropriate medical evaluation cannot be attributed 
to another medical condition. FAPDs with pain or discomfort that occur at least four times a 
month for at least two months include irritable bowel syndrome (IBS), functional dyspepsia 
(FD), and functional abdominal pain-not otherwise specified (FAP-NOS), see Figure 1 for 
characteristics separating the sub-diagnoses. The first two studies in the thesis used the Rome 
III criteria2 and the last two studies used the Rome IV criteria.3Two studies assessing the 
differences between the Rome III and IV criteria concluded that children diagnosed with the 
Rome IV criteria were more likely to receive a FD or IBS diagnosis compared with children 
diagnosed with the Rome III criteria. The studies also concluded that there is an increased 
overlap between IBS and FD in Rome IV compared with Rome III.4,5 
 
 
Figure 1. Characteristics separating irritable bowel syndrome (IBS), functional dyspepsia 
(FD), and functional abdominal pain–not otherwise specified (FAP-NOS) according to the 
Rome IV criteria3. 
2.2 PREVALENCE AND IMPAIRMENTS ASSOCIATED WITH FAPDS 
The prevalence of FAPDs varies between studies, likely because of differences in source 
population, diagnostic criteria used, and diagnostic procedures. A recent meta-analysis found 
a worldwide-pooled prevalence of 13.5%,6 which is comparable to what has been found in 
Swedish studies.7,8 The prevalence of FAPDs in girls is 50% higher than in boys.6 FAPDs are 
associated with anxiety, depression, school absenteeism, parental work absenteeism,9 and 
with anxiety later in adulthood.10 A study that followed 392 children with FAPDs 5-15 years 
after their initial assessment showed that 41% of the children still had abdominal problems in 
adulthood.11 Another study of children with FAPDs found that two or more of the risk 
IBS 
•  Related to 
defecation 
and/or 
•  Change in 
frequency 
and/or form 
of stool 
•  Not releaved 
with laxatives 
FD 
•  Pain or 
discomfort in 
upper 
stomach   
and/or 
•  Early satiety 
and/or 
•  Fullness after 
normal sized 
meal 
FAP-NOS 
•  Insufficient 
criteria for  
IBS or FD 
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factors: high baseline levels of pain intensity, functional disability, or anxiety were associated 
with increased functional disability six months later.12 Children with FAPDs report lower 
quality of life than healthy children,9 with levels comparable to and even lower than children 
with chronic somatic disorders such as inflammatory bowel disease.13,14 In Sweden, children 
with FAPDs account for 11% of all visits in secondary pediatric care and 25-30% of the visits 
to pediatric gastrointestinal units and abdominal pain is the second most common cause for 
visiting pediatric emergency services.15 The combination of high prevalence, associations 
with school and parental work absenteeism, and large health care consumption render 
substantial societal costs. The average cost for assessing a child with FAPDs within tertiary 
care in USA exceeds US$600016 and a study from the Netherlands estimated a mean annual 
cost of US$3122 for a child with FAPDs, including costs from both the healthcare and the 
societal perspective.17 There are potentially great gains to be made, both to the individual and 
to the society, if children with FAPDs were treated in an effective and cost effective way. 
2.3 ETIOLOGY AND CONTRIBUTING FACTORS 
It is a widely held view that the cause of FAPDs is multifactorial, with biological, social, and 
psychological factors interacting during development and maintenance of the disorders.18 An 
overview of factors shown to contribute to pediatric FAPDs is described below.  
2.3.1 Visceral sensitivity and vigilance 
A common feature in patients with FAPDs is visceral sensitivity, which refers to a lowered 
threshold for sensing pain and other symptoms from the gastrointestinal tract. Visceral 
sensitivity has been shown in both adults19 and children20 with IBS. A large study with five 
cohorts of adult patients with FAPDs showed that symptom severity gradually increased with 
increased levels of visceral sensitivity.21 In a study of a psychological treatment for adult IBS, 
a decrease in visceral sensitivity was found to mediate an improvement in abdominal 
symptoms.22 Visceral sensitivity is closely related to vigilance, representing a tendency to pay 
attention to or to notice abdominal symptoms. If symptoms are perceived as fearful, the 
vigilance will likely be increased as a means to protect the individual from harm (see The fear 
and avoidance model below.23) About 10% of patients with an infectious gastroenteritis 
experience remaining IBS-like symptoms after the infection has healed. 24 This development 
may involve increased visceral sensitivity,24 but also respondent conditioning,25 and changes 
in the gut microbiota,26 described below. 
2.3.2 Gastrointestinal-specific anxiety and avoidance behaviors 
Gastrointestinal-specific anxiety (GSA) is anxiety directed towards gastrointestinal 
symptoms.27 GSA includes visceral sensitivity, vigilance toward symptoms, fear and worry 
about symptoms, and avoidant behavior.27 In a study of 1021 university students where 
different aspects of anxiety were assessed GSA was found to be the strongest predictor of 
IBS.28 Pathological GSA has been shown to occur in the absence of anxiety disorders and 
external stressors, and may therefore have a unique explanatory value of IBS.28 GSA predicts 
gastrointestinal symptoms and quality of life in adults diagnosed with IBS.29 Decreased GSA 
has been shown to mediate symptom change in psychological treatments for adults with 
IBS30 but this has not been investigated in pediatric FAPDs. Avoidance behaviors are part of 
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the GSA construct but reduced avoidance behaviors have also independently been shown to 
mediate symptom improvement in adults30,31 and adolescents32 with IBS. The function of 
avoidance  behaviors is usually to reduce unpleasant feelings or fears. Patients with FAPDs 
may avoid symptom-provoking foods and situations perceived as difficult to endure with 
symptoms. Avoidances may also include controlling strategies such as long toilet visits, 
distraction from symptoms, and safety behaviors like arranging to be picked up if symptoms 
should occur.  
2.3.3 Pain perception and regulation 
Abdominal pain or discomfort is the common feature for IBS, FD, and FAP-NOS. Pain is a 
naturally aversive stimuli and the inherent response for individuals who experience pain is to 
do something to reduce the pain. These reactions to pain, such as withdrawal from a 
dangerous situation or taking care of a wound, have evolutionary advantages because it 
protects the individual from further harm.  
The International Association for the Study of Pain has the following definition of pain: “An 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage”.33 Pain is a subjective experience that can be 
affected by factors like cognitions, interactions with others, and emotions. High or low pain 
can be classically conditioned to a neutral stimuli, which later affects perception of pain level 
when paired with moderate pain.34 Attention to pain (vigilance), depressive mood, and 
anxiety towards pain are factors that have been shown to amplify pain perception.35,36 Pain 
may both proceed and be proceeded by emotional distress in serial interactions.37  
Nociceptive pain is pain that occurs as a consequence of tissue damage or an inflammatory 
process. Signals from nociceptors (pain receptors) are transported via nerves to the dorsal 
horn in the spinal cord where signals are reconnected to the brain. Pain signals may be 
amplified or inhibited both in the dorsal horn (bottom-up) and the brain (top-down).35 In 
functional pain the brain receives pain signals without nociceptive stimulation or with only a 
low degree of nociceptive stimulation.35 The human brain does not perceive nociceptive or 
functional pain differently. The visceral sensitivity seen in patients with FAPDs may be 
related to dysfunctions in pain modulatory systems. A study found that adolescents with 
FAPDs had impairments in conditioned pain modulation, compared with healthy controls. 
Conditioned pain modulation is thought to reflect reduced efficiency in descending inhibitory 
pain systems.38 Such deficit in pain inhibition has also been shown in experimental studies in 
adults with IBS.39,40 
2.3.4 Brain-gut axis and the gut microbiota  
The quotation from Hippocrates ”All disease begins in the gut” has gained increased validity 
in the last few years as the gut microbiota has been suggested to play a role not only in 
FAPDs,41 but also in disorders like obesity, autism, and cardiovascular disease.42 The gut 
microbiota consists of microorganisms within the gastrointestinal tract that are involved in a 
bidirectional communication between the gut and the brain, the brain-gut axis, involving the 
immune system, the hormonal system, and the neural system. Stress induced by maternal 
separation has been shown to change the microbiota in rhesus monkeys and mice43,44 and 
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experimental change of the microbiota has been shown to affect behavior.45 Cross-sectional 
studies have shown that some patients with IBS have a different gut microbiota compared 
with healthy controls while others do not seem to differ.26 Most studies of the microbiota 
have been conducted within animal models, but it is a rapidly growing research field that may 
lead to future advancements in treatments for FAPDs and other conditions.46 The 
hypothalamic pituitary axis, also known as the stress axis, is part of the brain-gut axis. The 
interactions within the brain-gut axis may help explain stress related associations such as the 
link between vulnerability to FAPDs in adulthood and traumatic experiences in childhood.47 
The role of stress is emphasized in many treatments for FAPDs and several protocols include 
relaxation techniques, as a way of coping with stressors. 
2.3.5 Parents as context and the role of gender 
There is a clustering of FAPDs within families, which is assumed to have both genetic and 
social learning explanations.48-50 Parents are the most important persons for a child’s 
development and constitute a major part of the child’s context. Parents may both reinforce 
and model pain behaviors and fear toward pain stimuli. In a study by Walker et al,51 parents 
were instructed to respond to their children’s pain complaints by attention, distraction or with 
no specific instruction. Children who received attention for their pain complaints engaged 
twice as much in complaining compared with children in the no specific instruction-group. 
Children who were distracted complained half as much as children in the no specific 
instruction-group. The results for self-rated gastrointestinal symptoms were similar to the 
results for the pain complaints. Children rated distraction as more supportive than attention. 
The parents however, rated distraction as a possibly more harmful approach than attention. 
The study shows that parental behavior can influence a child’s experience of gastrointestinal 
symptoms and that parents may contribute to both amplification and inhibition of their child’s 
perceived pain. The same study also showed that attention from parents increased symptom 
complaints more for girls than for boys, which gives a potential lead as to why FAPDs are 
more prevalent in girls than in boys.51 Expectations related to gender, where the sick-role 
might be more socially accepted in females, may contribute to the development and 
maintenance of FAPDs. 
A review of experimental and observational studies concluded that parental responses to child 
pain behaviors seem to affect development and maintenance of functional abdominal pain 52. 
Another study showed that family functioning was more related to pain-related disability than 
pain intensity in children with chronic pain 53. This may be one explanation why some 
children are severely disabled by their abdominal pain whereas others are less hindered.  
2.3.6 Anxiety, depression, and coping strategies 
Anxiety and depression are associated with FAPDs but it is unclear whether they precede or 
are preceded by FAPDs. Like in pain perception and emotional distress this interaction may 
appear interchangeably.37 However, a meta analysis of longitudinal studies showed that 
anxious and depressed mood provide a twofold risk of developing IBS in adults.54 
Children with FAPDs have been shown to use more avoidant coping than children without 
abdominal pain.55 In a cross-sectional study of children with FAPDs or inflammatory bowel 
disease (IBD) maladaptive coping styles such as catastrophizing and social isolation were 
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found to be associated with depression and functional disability for both groups. In the same 
study Van Tilburg et al also found that patients with FAPDs engaged in more coping, both 
positive and negative, than patients with IBD.56 This might reflect that while medical 
treatments are available for children with IBD, children with FAPDs are more prone to rely 
on coping strategies. Another possible explanation is that the tendency to use coping 
mechanisms might contribute to the development of FAPDs. Catastrophizing about 
symptoms may lead to symptom prioritization and perception of symptoms as threatening, 
closely related to visceral sensitivity, vigilance and gastrointestinal-specific anxiety. 
In a newly published article of recommendations for clinical practice, Keefer et al 
establishes that gastrointestinal disorders, both functional and those with a clear somatic 
cause, cannot be disentangled from their psychological context. The authors conclude that 
“the substantial burden of these diseases is co-determined by symptom and disease severity 
and the ability of patients to cope with their symptoms without significant interruption to 
daily life”.57 This conclusion generalizes far beyond gastrointestinal disorders, and will 
hopefully gain incdreased validity and influence in both somatic and psychiatric care. 
2.4 THEORETICAL FRAMEWORKS 
Interactions of factors related to FAPDs can be understood within different theoretical 
frameworks. The biopsychosocial model, the learning theory, and the fear and avoidance 
model are shortly described below. They are mutually inclusive and may all contribute to the 
understanding of the etiology of FAPDs. 
2.4.1 The biopsychosocial model 
The biopsychosocial model (BPS) was developed as a reaction to the biomedical perspective 
in which illness and disease are regarded as caused by purely biological mechanisms. The 
BPS was first described 1977 by Engel.58 In the BPS biological, psychological, and social 
factors all play a role in development and course of illness and disease. The BPS has been 
particularly influential within the field of chronic pain.59 Levy at al base their report of 
psychosocial aspects of FAPDs on the BPS and conclude that all aspects of the model need to 
be addressed in treatments for FAPDs,60 which is also concluded in a recent overview of 
biopsychosocial aspects of FAPDs.18 However, the BPS is general and does not give any 
guidance of how the different factors interact in the emergence of FAPDs and how they 
should be addressed in treatment.  
2.4.2 Learning theory 
According to the learning theory behaviors are learned via respondent conditioning, operant 
conditioning, or social learning. Respondent conditioning occur when a neutral stimulus is 
paired with a conditioned stimulus.61 The stimuli must occur in close timing for learning to 
take place and repeated pairings are sometimes necessary. In an experimental study, 
participants responded with fear to a non-painful abdominal stimulus that had previously 
been paired with a painful abdominal stimulus.25 Such learning may be present in the 
development of functional gastrointestinal disorders. Operant conditioning concerns learning 
via consequences, appearing after the behavior.62 Reinforcement of a behavior increases the 
behavior’s occurrence and punishment decreases it. Attention from parents can be a potent 
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reinforcer for different kinds of behaviors in children. Another powerful reinforcer is 
immediate symptom relief, which may occur as a consequence of avoidant behavior. Social 
learning or modeling is learning by imitation of behaviors.63 Language, how to behave in 
social situations, and how to cope with stressors or pain may be learned via modeling. The 
strengths of learning theory include the firm ground of experimental studies of both animal 
and human behavior and its usability to understand how behaviors arise and how behaviors 
can be changed.  
2.4.3 The fear and avoidance model 
In the fear and avoidance model for chronic pain, pain can be interpreted as either fearful or 
harmless.64 When pain is perceived as fearful, avoidance behavior is activated to protect the 
individual from harm. Avoidance behavior may also be activated by a perceived threat 
without the conscience feelings of fear.65 A neutral stimulus, such as a non-painful abdominal 
signal, may be paired with an aversive stimulus, such as abdominal pain (respondent 
conditioning).25,66After this pairing the neutral stimulus too can provoke avoidance behavior. 
When pain is acute, avoidant behavior is an appropriate response, aiming to minimize 
damage to the individual. In functional pain however, avoidant behavior will operate together 
with fear of pain and vigilance to symptoms and maintain pain and disability.23 In FAPDs, 
avoidant behaviors are often overt (such as avoidance of symptom-provoking food) but can 
also be covert (such as avoidance by distraction from symptoms). The avoidance prevents 
new learning of being able to cope with symptoms and a vicious circle of fear and avoidance 
is formed. The fear and avoidance model was originally developed for adults but is widely 
used in different settings and has shown a good fit for the development of functional 
disability in children and adolescents with chronic pain.67  
2.5 TREATMENTS IN PEDIATRIC FAPDS 
2.5.1 Non-psychological treatments  
Cochrane reviews have found that the scientific support for the effectiveness of non-
psychological treatments in pediatric FAPDs is weak. Pharmacological treatments are 
effective in adults68, but for children they have not been able to show superiority compared 
with placebos.69 A widely used elimination diet in IBS is the FODMAP diet, restricting 
foods with highly fermentable oligo-, di-, and monosaccharides, and polyols. It has been 
shown to decrease symptoms in adults with IBS,70 but there is no support for the FODMAP 
diet in children.71 Also, it can be argued that elimination diets restricting children’s nutritional 
intake and pharmacological medications with potential side effects should not be first hand 
treatment choices for growing children. To eliminate gluten and lactose is common in both 
children and adults with FAPDs. However, in a recent double-blinded placebo-controlled 
randomized study adult participants with suspected non-coeliac gluten sensitivity did not 
experience more symptoms on days with gluten compared to on days with 
placebo.72Similarly, no difference in symptoms was found in a double-blinded placebo-
controlled study where children with reported lactose sensitivity received lactose or 
placebo.73 There is no support for fiber based interventions, but there is some support for the 
use of probiotics. However, recommendations on specific probiotics cannot yet be given.71 
Yoga therapy has not been proven effective in pediatric FAPDs.74  
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2.5.2 Psychological treatments 
Cognitive behavioral therapy (CBT) and hypnotherapy have been shown to effectively reduce 
pain in pediatric FAPDs, but a recent Cochrane review concludes that the evidence is of low 
quality and includes only little proof of long-term benefits.74 Also, evidence regarding 
improvements in quality of life, daily functioning, anxiety, and depression in CBT and 
hypnotherapy for pediatric FAPDs is lacking.  However, two large randomized controlled 
trials not included in the Cochrane review75,76 were recently published showing good results 
on several outcome measures, strengthening the support for CBT. There is no support for 
written self-disclosure in pediatric FAPDs.74 Considering the high prevalence of FAPDs and 
the significant burden for children and their families there is a need for more high-quality 
research assessing not only symptoms, but also function and quality of life for children with 
FAPDs.55  
2.5.3 Cognitive behavioral therapy (CBT) 
CBT is an established form of treatment for both psychiatric and somatic conditions77 and 
CBT is also the most studied psychological intervention in pediatric FAPDs.74 However, 
many studies of CBT for pediatric FAPDs suffer from methodological limitations. Such 
limitations include small sample sizes, not pre-specified primary outcome measure, 
inadequately described interventions, and lack of relevant assessments such as function and 
quality of life. Large well-designed trials typically show smaller effect sizes than small trials 
of lower quality. For an overview of RCT:s of CBT for pediatric FAPDs from 1990 to this 
date, see Table 1. 
The CBTs for FAPDs that have been tested in randomized controlled trials include a number 
of different components such as relaxation,55,78-81 breathing exercises,55,80,82 cognitive 
techniques for changing thoughts,55,78,79,81 exposure exercises, 75 distraction 
techniques,55,79,81,82 positive self-statements,55,79,80,82 and parental interventions.55,75,76,78-80,82 
Most treatments consist of several components and it is not clear which ones are effective or 
what the potential working mechanisms are. Also, there is a risk that treatments use 
components that are not coherent and even pull in opposite directions.32 Therefore there is a 
need for studies that can reveal active components and potential working mechanisms in CBT 
for FAPDs.55,74 
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Table 1. Randomized controlled trials of cognitive behavior therapy for pediatric FAPDs  
Author 
(Year) 
Inter-
ventions 
 
Sample  
Size  
(Mean 
age) 
Assessed 
Symptoms 
Assessed 
Function/
diability 
Assessed 
Quality 
of life 
Strengths Limitations 
Lalouni  
(2018, not 
published) 
10 weeks  
Internet-CBT 
vs. TAU 
 
90 
(10.2) 
✓* 
 
✓* 
 
✓* 
 
Includes 
health 
economy 
TAU not 
standardized 
Levy 
(2017) 
Brief CBT 
vs. education 
and support  
 
316 
(9.4) 
✓ 
 
✓* 
 
✓* 
 
Large 
sample 
Active 
control 
 
No effect on 
primary 
outcome 
 
Bonnert 
(2017) 
10 weeks 
Internet-CBT 
vs. WL 
101 
(15.5) 
✓* 
 
✓* 
 
✓* 
 
Effects 
on a large 
range of 
measures 
 
WL control  
Groß and 
Warsch-
burger 
(2013) 
 
6 sessions in 
group vs. 
WL 
29 
(9.6) 
✓* 
 
- ✓* 
 
Large 
effects 
WL control 
Small study 
Van der 
Veek 
(2013) 
6 sessions 
vs. 
6 sessions 
with 
pediatrician 
  
104 
(11.9) 
✓ 
 
 
 
✓ 
 
✓ 
 
Potent 
control 
condition 
 
 
No 
difference 
between 
groups 
Levy  
(2010, 
2013) 
3 sessions 
family 
intervention 
vs. 
Education 
 
200 
(11.2) 
✓ * ✓ - Large 
sample 
Active 
control 
 
 
Small effect 
sizes 
 
Duarte  
(2006) 
4 sessions 
family 
intervention 
vs. SC 
 
32 
(9.2) 
✓ * - - Effects in 
pain freq. 
Small study  
Robins 
(2005) 
5 sessions 
family 
intervention 
vs. SC 
86 
(11.3) 
✓ * ✓ * 
  
- Assessed 
school 
absence 
 
Only 
completers 
analyses 
(n=69)  
 
Sanders 
1994 
6 sessions 
family 
intervention 
vs. SC 
44 
(9.2) 
✓ * 
 
✓ * 
 
- Assessed 
treatment 
expectan-
cies 
 
No flow-
chart or 
description 
of drop-outs 
Vs. = Versus, TAU = Treatment as usual, SC = Standard care, WL = Waiting list, Freq. = frequency 
✓= Assessed 
* =  Significant difference between groups 
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2.5.4 Exposure-based CBT  
Exposure is a key component in CBT and improvements in child functioning after CBT for 
anxiety disorders have been related to the use of exposure exercises.83 Exposures within CBT 
comprise exercises in which the patient provokes symptoms (interoceptive exposure), 
approach feared situations (in-vivo exposure), or imagine painful or intrusive thoughts, 
feelings, or memories (imaginal exposure). During the exposures the patient gains new 
experience of being able to cope with the symptoms, which is likely crucial for the 
improvement of symptoms and function. Exposure to painful stimuli may be particularly 
challenging to children and parents since symptom reduction usually do not occur as fast as in 
exposure for anxiety symptoms. Exposure exercises for patients with FAPDs include 
provoking symptoms by for example eating symptom-provoking food or wearing a tight belt 
(interoceptive exposure) and approaching difficult situations such as school or physical 
exercise (in-vivo exposure). It also includes minimizing control behaviors such as frequent 
toilet visits or extensive resting.  
Exposure therapy was invented by Mary Cover Jones in the 1920’s.84 Jones conducted a 
series of experiments with young children and concluded that in-vivo exposure was the most 
effective method in reducing fear. Jones also concluded that social learning was helpful, but 
that discussion and distraction were ineffective. Exposure therapy is based on the principles 
of learning theory. 
Craske et al developed a CBT protocol targeting gastrointestinal specific anxiety in adults 
with IBS that included interoceptive exposures to visceral sensations.85 Craske et al 
concluded that the visceral sensitivity and vigilance in IBS resembled the sensitivity of bodily 
signals seen in panic disorder and modeled the treatment after exposure-based CBT for panic 
disorder.86 The treatment was compared to stress management and attention control with 
results favoring CBT with interoceptive exposures. Ljótsson et al developed an exposure-
based CBT protocol with both interoceptive and in-vivo exposures for adults with IBS. In 
Ljótsson’s treatment the exposure exercises are accompanied by brief mindfulness exercises 
to increase the effects of the exposures. Several studies evaluating Ljótssons’s treatment 
protocol delivered via the internet have shown large effects on both symptoms and quality of 
life.87-90 The treatment has been proven to be superior to an intervention consisting of stress-
reduction, relaxation, and dietary advice.91 Exposure-based CBT has also been shown to be 
effective on a wide range of outcomes including symptom severity, quality of life, and daily 
functioning for adolescents with IBS.75  
2.5.5 Engaging parents in the treatment 
Engaging parents in the treatment for children do not necessarily increase the treatment 
effects. In fact, in a meta analysis of CBT for children with anxiety disorders treatments with 
or without parental involvement showed no significant differences in effect.92 However, the 
comparison was hampered by the heterogeneity of components used in the parental modules. 
If the parental modules are of good quality and coherent with the overall treatment approach, 
the parents can act as co-therapists during treatment. Parents can also help their child sustain 
the treatment gains after the treatment has ended. In exposure-based CBT for FAPDs, parents 
can facilitate and encourage the child’s exposure exercises, reinforce and model healthy 
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behaviors, and decrease attention to pain behaviors. Such parental strategies are highly 
compatible with the exposure-based approach. Indeed, not addressing parental behaviors may 
even undermine the treatment as some parents to children with pain disorders have a 
tendency to restrict their children’s pain-inducing activities.93 Parental involvement has been 
used in CBT-studies of FAPDs in combination with strategies for the child,55,75,76,78-80,82,94 but 
to the best of our knowledge never in combination with exposure-based CBT for children 8-
12 years.  
2.5.6 Internet-delivered CBT  
There is a shortage of CBT therapists in healthcare, which is why innovative ways of making 
CBT available for children with FAPDs are needed. A possible way of making CBT more 
available is to use internet-delivered CBT (Internet-CBT). In Internet-CBT the treatment 
content is delivered via texts, images, and film clips and therapist support is provided via text 
messages. Internet-CBT carries several advantages compared to CBT delivered in a 
traditional format with weekly visits at a clinic: patients can work with the treatment at any 
time during the week without taking time off from school or work, the treatment can be 
delivered regardless of the geographical distances, less therapist time per patient is needed, 
and the risk for therapist drift is small.95  
Internet access is generally high among children. According to the Swedish Media Council 
99% of all Swedish 9-12 year old children have internet access in their homes.96 The number 
of trials of pediatric Internet-CBT do not match children’s high access to the internet. We 
conducted a comprehensive review and meta-analysis of Internet-CBT for children and 
adolescents in 2016 and found only 19 studies from the fields of behavior medicine (n=10) 
and psychiatry (n=9) in our worldwide search.95 Of the interventions within behavioral 
medicine eight out of 10 concerned pain conditions.97-104 There is a gap between available 
treatments and the need of treatments for children with FAPDs. This thesis may help bridging 
that treatment gap by studying a treatment and delivery method that may be implemented on 
a broad scale, if proven effective.  
2.5.7 Cost effectiveness 
Given some of the advantages of Internet-CBT (e.g. less therapist time per patient and no 
time off from school or work) this form of treatment is potentially cost effective. In an 
evaluation of a brief telephone delivered CBT Levy et al concluded that the CBT intervention 
was more effective in reducing health care visits for abdominal pain and missed school days 
than an educational support, but a cost effectiveness analysis was not conducted.76 Law et al 
conducted a cost effectiveness analyses of a randomized controlled trial for chronic 
pain101and concluded that Internet-delivered CBT was equally cost effective as an internet 
education intervention.105 Exposure-based CBT delivered via the internet has been shown to 
be cost effective for adult IBS.89,106 Internet-CBT has also been shown to be cost effective in 
pediatric obsessive compulsive disorder107but analyses of cost effectiveness in pediatric 
FAPDs are lacking. 
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2.6 SUMMARY OF THE BACKGROUND OF THE THESIS 
Pediatric FAPDs are prevalent and associated with low quality of life, functional disability, 
and a high health care consumption. The etiology of FAPDs is multifactorial and includes 
biological, psychological, and social factors, which are all included in the biopsychosocial 
model. Etiological factors include visceral sensitivity and anxiety, vigilance to symptoms, 
altered pain regulation, and parental responses to the child’s symptoms.  Theoretical 
frameworks in which pediatric FAPDs can be understood are the learning theory and the fear 
and avoidance model. These theories give guidance about how psychological treatments can 
be designed and how parents and other important adults can respond to children with FAPDs. 
Pharmacological and dietary treatments have not been proven effective for pediatric FAPDs, 
but the results for CBT are promising. Most CBT protocols studied in clinical trials include 
multiple components, which is why there is a need for studies that can reveal active 
components and potential working mechanisms in CBT for pediatric FAPDs. 
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3 AIMS 
3.1 OVERALL AIM  
The overall aim of the thesis was to develop and evaluate a psychological treatment for 
children with FAPDs that could help the children decrease their symptoms and increase their 
quality of life. Theoretically, the premise was to explore if and how exposure to abdominal 
symptoms and avoided situations were beneficial for young children with FAPDs. A further 
basis for the treatment was that it should be scalable. Therefore, the internet format was a 
chosen.  
3.1.1 Study I 
The aim of Study I was to develop an exposure-based CBT for children with FAPDs and to 
test its feasibility, acceptability, and potential effectiveness.  
3.1.2 Study II 
In Study II the treatment content from Study I was transformed into an internet treatment, 
Internet-CBT, and feasibility, acceptability, and potential effectiveness were again evaluated. 
We hypothesized that the treatment would be feasible, acceptable and potentially effective 
based on the results in Study I. 
3.1.3 Study III 
The aims of Study III were to assess effectiveness and cost effectiveness of the Internet-CBT 
compared with treatment as usual. We hypothesized that the Internet-CBT would be effective 
and cost effective. 
3.1.4 Study IV 
In Study IV we used data from Study III and the aim was to assess if gastrointestinal-specific 
anxiety and avoidance behaviors mediated a change in gastrointestinal symptoms for children 
receiving Internet-CBT compared with children receiving treatment as usual. A further aim 
was to assess if baseline values of the proposed mediators moderated the mediation. 
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4 EMPIRICAL STUDIES 
4.1 THE INTERVENTION 
The intervention was based on the exposure-based CBT for adults90 and adolescents75 with 
IBS and on parental support commonly used in parenting programs.108,109 The main 
components in the treatment were exposure to symptoms and to situations in which 
symptoms were perceived as difficult to have or even intolerable. Since exposure to painful 
stimuli can be challenging for both children and their parents, emphasis was put on 
explaining the treatment rationale. The role of avoidant and controlling behaviors in 
maintaining and amplifying symptoms was stressed. In the parental modules, the role of 
parental reinforcement, such as attention to the child’s pain behavior, was highlighted as a 
potential maintaining factor of the symptoms. Exposure to symptoms was presented as a 
means to decrease symptoms and limitations in the child’s everyday life. The exposure 
exercises were based on challenging avoidances of symptom-provoking stimuli, avoided 
situations, control strategies, and safety behaviors, mapped by the child in the first module. A 
short mindfulness exercise: Stop, Observe, and Let go (SOL) was used by the children to 
increase the effect of the exposures. In SOL the children would first stop what they were 
doing, observe their abdominal symptoms for a short while, and then let go of their symptoms 
and continue to do what they were doing before. The therapist encouraged the child to 
increase the difficulty of the exposure exercises during the treatment. Most parents used a 
printed token game to reinforce their child’s work with exposure exercises, while others 
preferred to encourage their child’s work in another way. In Study I the intervention was 
developed and evaluated face-to-face at the clinic. After Study I the treatment was adapted to 
the internet format (Internet-CBT) and used in the Studies II-IV. 
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4.2 THE INTERVENTION VIA INTERNET 
The Internet-CBT was delivered via the BIP platform, using child-adapted templates 
supporting texts, images, sound files, and video material. The BIP platform has previously 
been used in randomized controlled trials of pediatric anxiety disorders,110 obsessive-
compulsive disorder,111 and irritable bowel syndrome.75 The Internet-CBT consisted of 10 
modules for the children and 10 modules for the parents. Parents and children worked with 
the child modules together. Both parents, if applicable, were encouraged to take part of the 
parental modules. Therapist support consisted of written comments and messages within the 
treatment platform. Additional telephone calls were used if further support was needed.  
 
 
 
 
 
 
 
 
 
Figure 1. Screenshots from Internet-CBT 
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4.3 STUDY I: EXPOSURE-BASED COGNITIVE BEHAVIOR THERAPY FOR 
CHILDREN WITH ABDOMINAL PAIN: A PILOT TRIAL 
Aim  
The aim of Study I was to develop and evaluate the treatment protocol of exposure-based 
cognitive behavioral therapy for children with abdominal pain and their parents. The 
evaluation included potential efficacy, feasibility, and acceptability. 
Methods  
We included 20 children 8-12 years with pain-related functional gastrointestinal disorders 
(Rome III criteria) and their parents in this open study. The participants came to the clinic 
once a week for 10 weeks and received face-to-face cognitive behavioral therapy based on 
exposure exercises and parental support. Attendance to the sessions, engagement in the 
exposure exercises, satisfaction with treatment, and perceived usefulness were measures of 
feasibility and acceptability. Within-group effects from baseline to post-treatment and from 
baseline to 6-month follow-up were calculated using two-tailed dependent t-tests. The 
primary outcome was pain intensity and secondary measures included gastrointestinal 
symptoms, quality of life, anxiety, school absenteeism, and parental responses to the child’s 
pain behavior.  
Main Results  
Satisfaction with the treatment and attendance to the sessions were high. Children engaged in 
the exposure exercises to a large extent and perceived the treatment to be useful. The children 
showed significant improvements in pain intensity from baseline to post-treatment with a 
small effect size (Cohen’s d=0.40, P=0.049). The results were further improved at 6-month 
follow-up showing a large effect size (d=0.85, P=0.004). Significant improvements were also 
seen at post-treatment in gastrointestinal symptoms, quality of life, anxiety, school 
absenteeism, and parental responses to the child’s pain behavior. These results were 
maintained or further improved at 6-month follow-up. 
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4.4 STUDY II: INTERNET-DELIVERED COGNITIVE BEHAVIORAL THERAPY 
FOR CHILDREN WITH PAIN-RELATED FUNCTIONAL 
GASTROINTESTINAL DISORDERS: FEASIBILITY STUDY 
Aim 
In Study II the aim was to evaluate the treatment developed in Study I, which was now 
adapted to the internet (Internet-CBT), for children with abdominal pain and their parents. 
The evaluation included potential efficacy, feasibility, and acceptability. 
Methods 
We included 31 children 8-12 years with pain-related functional gastrointestinal disorders 
(Rome III criteria) and one of their parents in the study. We used a within-group design with 
measures conducted at baseline, post-treatment, and at 6-month follow-up. Primary outcome 
was child-rated gastrointestinal symptoms. Secondary outcomes included quality of life, pain 
intensity, gastrointestinal-specific anxiety, school absence, and parental responses to the 
child’s pain behavior. Feasibility and acceptability were assessed with measures of 
treatment satisfaction, subjective treatment effect, and number of completed modules. 
Multi-level linear mixed models were used to estimate means and Cohen’s d effect sizes. 
The treatment was therapist guided Internet-CBT with 10 weekly modules for both children 
and their parents.  
Main Results 
At the post-assessments the within-group effect size was large and significant for the primary 
outcome child-rated gastrointestinal symptoms (d=1.14, P<0.001), which was maintained at 
6-month follow-up (d=1.40, P<0.001). Results for quality of life, pain intensity, 
gastrointestinal-specific anxiety, school absence, and parental responses to the child’s pain 
behavior were also significant and within group effect sizes varied between medium and 
large for both parents’ and children’s assessments. From baseline to 6-month follow-up all 
these measures showed a large within group effect size. Both children and parents expressed 
overall satisfaction with the treatment and most participants reported a positive treatment 
effect. Attendance to the treatment was high among both children and parents. 
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4.5 STUDY III: EFFECTIVENESS AND COST EFFECTIVENESS OF COGNITIVE 
BEHAVIOURAL THERAPY VIA INTERNET FOR CHILDREN WITH 
FUNCTIONAL ABDOMINAL PAIN DISORDERS: A RANDOMIZED 
CONTROLLED TRIAL 
Aim 
The aim in Study III was to compare the effectiveness and cost effectiveness of Internet-CBT 
and treatment as usual for children with functional abdominal pain disorders and their 
parents. 
Methods 
We included 90 children 8-12 years with functional abdominal pain disorders (Rome IV 
criteria) and one of their parents. Participants were randomized to 10 weeks Internet-CBT 
with therapist support or treatment as usual. Assessments were conducted at baseline, weekly 
during treatment, at 10-week follow-up (post-assessment) and at 6-month follow-up. Primary 
outcome was child-rated gastrointestinal symptoms and secondary outcome measures 
included quality of life, gastrointestinal-specific anxiety, avoidance behaviors, and parental 
responses to the child’s pain behavior. Significant interaction effects between group and time 
based on restricted maximum likelihood mixed models were interpreted as effects of 
treatment. Effect sizes between and within groups were calculated as Cohen’s d. Costs for 
health care consumption and loss of productivity were collected at baseline, week 6 during 
the treatment and at 10-week follow-up. Generalized linear models were used to assess 
changes in mean cumulative costs between groups, controlling for baseline values.  
Main Results 
Children receiving Internet-CBT improved significantly with a medium effect size on the 
primary outcome gastrointestinal symptoms compared with treatment as usual (d=0.46, 
P=0.022). Improvements in the secondary outcomes quality of life, gastrointestinal-specific 
anxiety, avoidance behaviors, and parental responses to the child’s pain behavior were also in 
favor of Internet-CBT. Internet-CBT was found to be highly cost effective compared with 
treatment as usual. From the societal perspective there was a cost saving of US$1050 for 
every child who received Internet-CBT instead of treatment as usual. Children receiving 
Internet-CBT used significantly less health care resources during treatment compared with 
children receiving treatment as usual. 
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4.6 STUDY IV: MEDIATION AND MODERATION OF FEAR AND AVOIDANCE 
IN COGNITIVE BEHAVIOURAL THERAPY FOR CHILDREN WITH 
FUNCTIONAL ABDOMINAL PAIN DISORDERS. 
Aim 
In Study IV, data from the randomized controlled trial in Study III were used. The aim was to 
assess if gastrointestinal-specific anxiety and avoidance behaviors mediated a change in 
gastrointestinal symptoms for children receiving Internet-CBT compared with children 
receiving treatment as usual, and if baseline values of the proposed mediators moderated the 
mediation.  
Methods 
We used bi-weekly assessments of the proposed mediators gastrointestinal-specific anxiety 
and avoidance behaviors from the 90 included children (ages 8-12 years) with FAPDs and 
weekly assessments of children’s gastrointestinal symptoms assessed by the children’s 
parents. Univariate and multivariate growth models were used to test direct effects of the 
treatment on the outcome and the indirect effects of the proposed mediators and the 
moderated mediation. 
Main Results 
In the model, the treatment group significantly predicted the outcome, in favor of Internet-
CBT, consistent with the results in Study III. Also, treatment condition significantly predicted 
the slope of the proposed mediators (a-path) in favor of Internet-CBT and the proposed 
mediators were correlated with the outcome (b-path). The indirect effects of the cross-product 
of these paths (ab) were significantly different from zero for both gastrointestinal-specific 
anxiety ab = 1.58, 95% CI (0.43, 3.33) and avoidance behaviors ab =1.43, 95% CI (0.42, 
3.23). Further, baseline levels of the mediators moderated the mediation. 
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4.7 ETHICAL CONSIDERATIONS 
In all research, and particularly in research with children as participants, a thorough 
consideration of the ethical aspects of the procedures and methods is necessary. All studies 
included in the thesis were reviewed and approved by the Regional Ethical Review Board 
in Stockholm. Ethical aspects of particular consideration in the included studies were 1) the 
safety of the recruitment procedure, 2) the child’s informed consent, and 3) the safety of the 
technology used for assessments and treatment. The ethical considerations concerning these 
aspects are described below.  
To minimize the risk of including children in need of a medical treatment, all children were 
assessed by their physician before inclusion. The physicians certified that proper medical 
examinations had been performed to support the FAPD diagnosis. The studies’ PI, who is a 
pediatric gastroenterologist, had before Study I in consensus with other pediatric 
gastroenterologists decided which tests were obligatory. 
A clinical psychologist interviewed all children and their parents before inclusion in the 
study. During this interview, psychiatric comorbidity was assessed with the Mini 
International Neuropsychiatric Interview.112 In one part of the interview, the child was 
alone with the psychologist.  During this time the child was asked about school, friends, 
family, and if somebody had done anything against his or her will, such as hitting or 
touching in a way he or she did not want to be touched. This procedure was used to screen 
for psychosocial problems and abuse, which has been reported to be overrepresented in 
patients with FAPDs.60 If psychiatric illness, abuse, or psychosocial problems in need of 
immediate or other care were found, children were referred to appropriate treatments. All 
children included in the studies were enrolled as patients at the research clinic, which 
facilitated treatment documentation and referrals within the healthcare system. A child 
psychiatrist and the PI pediatric gastroenterologist were available for consultations during 
both the inclusion process and the treatment.  
Before the children and parents came to the clinic, they received written information about 
the research project and during the clinical interview; the psychologist gave a description of 
the study. The children were then asked if they wanted to join the study and were informed 
that they could cancel participation at any time, even if their parent(s) wanted to continue. 
If they wanted to participate in the study, the child gave oral consent and the parents gave 
written consent. 
The login to the treatment and the online assessments were accessed via a two-factor 
authentication, where the personalized logins and passwords were confirmed via text 
messages to the participants’ mobile phones, in accordance with regulations by the Swedish 
National Board of Health and Welfare. There is an ongoing discussion about technological 
security within BUP KFE (Child and Adolescent Psychiatry Clinical Research Unit) 
involving the BIP-team and the developers. The security of the online platform is of major 
importance and as technology advances the development of safety measures will continue. 
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5 DISCUSSION 
5.1 IS EXPOSURE-BASED CBT, FACE-TO-FACE OR ONLINE, FEASIBLE AND 
ACCEPTABLE FOR CHILDREN WITH FAPDS? 
Exposure to painful stimuli was a key component in the treatments and this was hypothesized 
to be difficult for both children and their parents. In exposure for pain, the symptom relief is 
usually delayed compared with the symptom relief seen in exposures for anxiety symptoms, 
which is why pain-provoking exposures can be very challenging. Also, the intervention 
included strategies to decrease parental reinforcement of their child’s pain behaviors, which 
was thought to be a tough eye-opener for some of the parents, who may have been 
reinforcing these behaviors for several years. In the face-to-face study (Study I) the therapist 
helped the families during the weekly sessions to adjust the level of difficulty of the exposure 
exercises so that it was acceptable but challenging throughout the treatment. All children in 
the study engaged in exposure exercises and most parents welcomed the parental strategies. 
The children and their parents attended a mean of 9.3/10 (93%) sessions and all children 
declared that the treatment had been helpful in dealing with their symptoms. Almost all 
children 19/20 (95%) were satisfied with the treatment. 
Before Study II, the treatment protocol used in Study I was converted into texts, images and 
animated films in 10 internet modules for children and parents, respectively. The main 
concerns were if children would engage in exposures without the face-to-face contact with 
the therapist and if this would increase the burden for the parents. Qualitative interviews with 
the parents (not reported in the thesis) showed that some parents were burdened by the 
intervention. However, 25/31 (81%) of the children completed 9 or 10 of the 10 treatment 
modules and 28/30 (90%) declared that the treatment had been helpful in dealing with their 
symptoms. There were no data available on the use of exposure exercises, but there were 
large within-group effect sizes of gastrointestinal symptoms (d=1.14, 95% CI 0.69-1.61), 
avoidance behavior (d=1.18, 95% CI 0.76-1.65), and gastrointestinal-specific anxiety 
(d=0.92, 95% CI 0.56-1.31), which suggests a successful use of the exposure-based 
treatment. In summary the exposure-based CBT seems to be feasible and acceptable to 
children and parents, both in a face-to-face setting and when delivered online.  
5.2 IS INTERNET-CBT CLINICALLY EFFECTIVE FOR CHILDREN WITH 
FAPDS?  
In Study III the treatment as usual group had higher symptom levels on the primary outcome 
measure at baseline compared with the Internet-CBT group, which may have been beneficial 
for the treatment as usual group. A more pronounced effect for participants with high levels 
of symptoms at baseline has been observed in pediatric pain patients.113 However, the 
participants in Internet-CBT showed significantly greater reductions on both the primary 
outcome and on most secondary outcomes including quality of life and avoidance behavior 
(also measuring daily functioning). The differences in effect sizes were moderate to large and 
the gains were maintained at 6-month follow-up for children in Internet-CBT. Therefore, the 
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firm conclusion is that Internet-CBT based on exposure exercises for children with FAPDs is 
clinically effective. 
5.3 IS INTERNET-CBT COST EFFECTIVE FOR CHILDREN WITH FAPDS? 
We hypothesized that Internet-CBT would be cost effective; both because adult studies of 
Internet-CBT in IBS had shown cost effectiveness89,106 and because we assumed that the 
expected effects gained would weigh more heavily than the additional costs of the low-
resource intervention. The results exceeded our expectations. Not only was Internet-CBT cost 
effective, but also cost saving. For every child treated with Internet-CBT instead of treatment 
as usual a gain of US$1050 was obtained. The statistical method used (generalized linear 
models) controlled for baseline differences. There was a 92% probability that Internet-CBT 
was cost effective compared with treatment as usual. 
The result in a cost effectiveness analysis is explained by two factors: differences in costs and 
differences in gains. The children in treatment as usual consumed significantly more 
healthcare resources than the children in Internet-CBT. They were also more impaired by 
reduced efficiency in school and school absence during treatment, even if this difference was 
not statistically significant. Gains in quality adjusted life years (QALYs) were observed for 
Internet-CBT, but not for treatment as usual, resulting in a statistically significant difference 
in QALYs in favor of Internet-CBT.  
5.4 DO GASTROINTESTINAL-SPECIFIC ANXIETY AND AVOIDANCE 
BEHAVIOR MEDIATE CHANGE IN GASTROINTESTINAL SYMPTOMS? 
Treatments should ideally be based on knowledge of its cause and operating mechanisms.114 
To shed some light on this we conducted the mediation analyses. We found that there was a 
significant treatment effect on the outcome in favor of Internet-CBT, similar in magnitude to 
the one found in Study III. We also found that treatment predicted the slope of the proposed 
mediators and that the mediators were correlated with the outcome. We conducted analyses 
of moderated mediation, using the baseline values of the mediators as moderators. The 
moderated mediation was significant for both gastrointestinal-specific anxiety and avoidance 
behavior indicating that children with higher baseline values on the mediators had a larger 
mediated effect. These analyses add further support to the role of gastrointestinal-specific 
anxiety and avoidance behavior as mediators of change and indicate that exposure-based 
CBT may be particularly valuable for children with high levels of symptom-specific fear and 
avoidance. 
5.5 LIMITATIONS 
There are some important limitations to the studies in this thesis. In Study I-II there were no 
control groups, which precludes causal inferences of the treatment effects. In all studies the 
children’s parents had a higher mean educational level than the mean educational level in 
Sweden, which decreases the generalizability of the results. In the first two studies 64% and 
in the RCT 77% of the parents had a university degree, compared with 56% of the females, 
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and 49% of both males and females in Sweden in the same age group (in the RCT 86% of the 
parents were female). There was a nationwide recruitment in Study II and III but the 
participants had to pay from their own pocket for one obligatory trip to Stockholm (or 
persuade their county council to pay the tickets). This procedure has likely resulted in a 
selected group with parents being very motivated, particularly the ones that had traveled very 
far (range 0.3-854 km). On the other hand, physicians within primary, secondary, and tertiary 
healthcare referred all participants to the study, which increases the generalizability of the 
study.  
5.6 CLINICAL IMPLICATIONS 
Considering the fine results of Internet-CBT for children (seen in the studies I-III) and 
adolescents with FAPDs,75 the high prevalence of pediatric FAPDs,6 and the low quality of 
life seen in the patient group,14 Internet-CBT should be made available to children and 
adolescents with FAPDs. Many families with children or adolescents with FAPDs seek 
healthcare,15 but since there are no evidence-based treatment options available for them the 
benefits are often small while the costs are high.  
Internet-CBT could either be situated within local units, such as primary or secondary 
healthcare centers, or it could be administered from a national internet unit like 
www.internetpsykiatrienheten.se for adults serving patients from all over Sweden. After a 
few days education CBT-psychologists could become therapists in Internet-CBT, based on 
knowledge obtained in an ongoing implementation study conducted within the research 
group.  
In our Internet-CBT studies we only met the children and parents once, which was before the 
inclusion to the study. This procedure made it possible to include children living in remote 
areas in Sweden. However, if the treatment is implemented in a regional setting it may be 
wise to follow up the intervention with a regular face-to-face meeting after treatment 
completion. If the treatment is implemented in a national setting, the patients’ local physician 
can follow up the patients face-to-face after the treatment. 
5.7 FUTURE DIRECTIONS 
In Study IV we found that children with high levels on avoidance and gastrointestinal-
specific anxiety at baseline showed a more pronounced mediating effect than children with 
low levels of the mediators at baseline. The treatment contains several examples of children 
with explicit avoidance behaviors and fear of symptoms (e.g., avoiding onion or being afraid 
of physical training) but no examples of more subtle avoidances (e.g., keeping a full schedule 
to distract from symptoms). For children with subtle avoidances the therapist emphasized the 
work with the mindfulness exercise to increase exposure of symptoms and decrease 
distraction. Likely there is room for improvement in the treatment by including examples of 
different kinds of avoidances and providing guidance on how to work with these.   
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An interesting research question for the future is to assess whether there are different working 
mechanisms at play in treatments with theoretically different approaches for pediatric FAPDs 
and also if it is possible to identify which children would benefit most from the respective 
treatments. Hypnotherapy is alongside with CBT the treatment with the strongest empirical 
support in pediatric FAPDs. As many CBT protocols include relaxation, which has 
similarities to hypnotherapy, it would be interesting to compare hypnotherapy to exposure-
based CBT, where relaxation is not included.  
Another research approach is to dig deeper into which factors contribute to emergence, 
maintenance, and relief of symptoms in experimental models. It is challenging to isolate any 
factors and particularly factors that may overlap or co-occur, such as symptom-related fear 
and avoidance. However, such efforts may be rewarding as information on working 
mechanisms can inform both the work with improving treatments and the development of 
preventative methods.
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6 CONCLUSIONS 
Internet-CBT can be recommended for children 8-12 years with FAPDs, and particularly to 
children with high levels of gastrointestinal-specific anxiety or children who are limited by 
their symptoms. The treatment has the potential to increase treatment availability and 
decrease suffering for a large group of children. Internet-CBT can reduce costs, both to 
families, to the healthcare system, and for society compared with regular care.  
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